Ching-Hua Lu Selected Research

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

11/2021	Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis.
1/2021	Humoral response to neurofilaments and dipeptide repeats in ALS progression.
1/2020	The potential of neurofilaments analysis using dry-blood and plasma spots.
12/2019	Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
1/2019	Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis.
1/2018	A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry.
8/2016	Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis.
6/2015	Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
5/2015	Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.
1/2014	The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Hua Lu Research Topics

Disease

10	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2021 - 01/2014
5	Disease Progression 11/2018 - 01/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2014
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2021
1	X-Linked Bulbo-Spinal Atrophy 12/2019
1	Acute-Phase Reaction 11/2018
1	Stroke (Strokes) 01/2018
1	Muscular Diseases (Myopathy) 03/2016
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2016
1	Nervous System Diseases (Neurological Disorders) 07/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2015
1	Central Cord Syndrome 03/2015

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
2	arimoclomolIBA 03/2016 - 01/2014
1	AntibodiesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	DipeptidesIBA 01/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2019
1	CreatinineIBA 12/2019
1	ProteomeIBA 11/2018
1	idarucizumabIBA 01/2018
1	Dabigatran FDA Link 01/2018
1	Neurofilament ProteinsIBA 01/2018
1	Valosin Containing ProteinIBA 03/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2016
1	AutoantibodiesIBA 05/2015
1	Indicators and Reagents (Reagents)IBA 05/2015
1	Neuroprotective AgentsIBA 03/2015
1	Minocycline (Cyclops)FDA LinkGeneric 03/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Superoxide Dismutase-1IBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2014